Drug profile · INN
meprobamate
MEPROBAMATE
meprobamate (MEPROBAMATE) is a gaba-a receptor; anion channel agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — meprobamate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 1
- Data quality
- 0.89
Quick answer
meprobamate (MEPROBAMATE) is a gaba-a receptor; anion channel agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel agonist
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
WO 2026029046
LIPIDE D'URÉE OU DE CARBAMATE AYANT UN GROUPE CYCLIQUE DANS UNE CHAÎNE LATÉRALE, NANOPARTICULES LIPIDIQUES DE CELUI-CI ET COMPOSITION PHARMACEUTIQUE ASSOCIÉE
granted -
US 12390419
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 12384743
Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof
granted -
US 11998639
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 11560354
Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof
granted -
US 11439597
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 10829443
Solvate form of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 10512609
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 10233174
Thiocarbamate prodrugs of tofacitinib
granted -
US 10195151
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 9828352
Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR)
granted -
US 9518050
Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity
granted -
US 8846908
Tricyclic carbamate JAK inhibitors
granted -
US 8735408
Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
granted -
US 8153668
Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate
granted -
US 7988956
Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
granted -
US 7851467
Carbamate compounds as 5-HT4 receptor agonists
granted -
US 7829723
Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate
granted -
US 7776879
Quinuclidine carbamate derivatives and their use as M3 antagonists
granted -
US 7777069
Prodrugs of carbamate inhibitors of IMPDH
granted
Frequently asked questions
What is meprobamate?
meprobamate (MEPROBAMATE) is a gaba-a receptor; anion channel agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for meprobamate?
MEPROBAMATE is a marketed brand name for meprobamate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of meprobamate?
meprobamate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.